ESC 365 - Protective actions of substance p in diabetes induced cardiac fibrosis

Open Access

Protective actions of substance p in diabetes induced cardiac fibrosis

Session: Extracellular matrix and cardiac remodelling

Topic: Fibrosis

Speaker: Doctor A. Widiapradja (Sydney, AU)

Event: Frontiers in CardioVascular Biology 2018

Congress Presentation

Add to my library

About the speaker

Doctor Alexander Widiapradja

University of Sydney, Sydney (Australia)

0 follower

5 more presentations in this session

The impact of ageing and biological sex on cardiac extracellular matrix composition and its clinical consequences

Speaker: Professor G. Kararigas (Reykjavik, IS)

Syndecans: key regulators of cardiac fibrosis

Speaker: Professor I. Lunde (Oslo, NO)

Role of tenascin-C (TNC) in pressure and volume overload.

Speaker: Professor B. Podesser (Vienna, AT)

Single-cell sequencing of the healthy and diseased heart reveals Ckap4 as a new modulator of fibroblasts activation.

Speaker: Doctor M. Gladka (Amsterdam, NL)

Mesenchymal stem cells transfected with minicircle-HIF-1a decreases LV adverse remodelling via release of cardioprotective miRNAs and pro-angiogenic factors

Speaker: Doctor E. Gara (Budapest, HU)

Access the full session

Extracellular matrix and cardiac remodelling

Speakers: Doctor A. Widiapradja, Professor G. Kararigas, Professor I. Lunde, Professor B. Podesser, Doctor M. Gladka...

About the event

Frontiers in CardioVascular Biology 2018

20 April - 22 April 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources